Unlike Germany, which announced the resumption of vaccination on the premise of prior notification of the side effects of the vaccine, Korea interpreted it as an announcement of'safety and benefit', and on the 18th of the UK Medical and Health Management Product Regulatory Authority (MHRA), “A very rare cerebral thrombosis after vaccination. Five additional cases of reaction were reported, and in detail,'under investigation' and the European Regulatory Agency (EMA)'s “The association between blood clots and vaccines cannot be completely excluded. Most of the announcements of “recommendations for adding this explanation to vaccine information” have been reduced.
MBC in the title of <British Health Authority "AZ vaccine does not cause blood clots">
British health officials have concluded that the AstraZeneca vaccine does not cause blood clots, Reuters reported. "There is no evidence that the AstraZeneca vaccine caused blood clots," said the UK Drug and Health Care Products Regulatory Authority. "The chance of a blood clot is less than 1 in 1 million, which is a natural occurrence." However, the UK Drug and Health Care Product Regulatory Agency explained on the 19th that "5 cases of cerebral thrombosis, a very rare and specific type of cerebral blood clots with platelet reduction, have been reported and are being investigated further."> reported on the 19th.
The Kyunghyang Shinmun was published under the title of “But” followed by “under investigation”.
<The European Medicines Agency (EMA) announced on the 18th that the AstraZeneca vaccine is “not related to
blood clots, it is safe and effective.” (omitted) Reuters reported that the European Medicines Agency's safety
committee (omitted) As a result of a close analysis of the causal relationship, it was reported that "we concluded
that there is no direct relationship." Commissioner Emma Cook announced the results on the day and said,
“The AstraZeneca vaccination has a far greater advantage than the risk.”> “But” followed by “under investigation”.
Yonhap News Resume AZ Vaccination in Europe at in the article
German Minister of Health said at a press conference "Resume vaccination from tomorrow as a result of consultations with the federal government and 16 states, the agency in charge of vaccine approval, Paul Errich Institute (PEI)" and Klaus Chihutech, head of PEI, said, I will explain the side effects," he added. "As this is a very rare case, it has become clear that the benefit of AZ vaccination outweighs the risk and that it is possible to continue vaccination."
Prime Minister Jeong Sye-gyun announced on the 19th in an urgent order, "WHO and EMA each announced the results of discussions such as the expert committee on the point that'AstraZeneca vaccination and the occurrence of blood clots are not related.' Considering the cases of adverse reactions identified so far, it was determined that there was no reason to stop the AstraZeneca vaccination currently in progress in Korea. "However, considering the situation to continue expanding the AstraZeneca vaccination, The public should not have any doubts or anxiety about the safety of the AstraZeneca vaccine," he ordered the convocation of the Vaccination Committee.
In a response to the National Assembly Preliminary Committee, Chung Eun-kyung said, "It is difficult to confirm evidence that blood clots are related to the vaccine, and blood clots are reported in Pfizer vaccine, so there are no clear signs to be attributed to the vaccine," he said on the day.
'Hankyoreh' said in the title of , "Political reasons such as vaccine competition between the US and UK and the tug of war between the EU and the UK were also affected. “The US is concerned about the reliability of the AstraZeneca vaccine, but there is an analysis that the background of actually delaying approval is the friendly attitude towards Pfizer and Modena, who competed for vaccine development,” he said. As a result of (MHRA) investigating thrombus reaction cases up to February, Pfizer vaccine had 38 times more blood clots than AstraZeneca's 30 episodes, but the criticism was focused on AstraZeneca.”
Vaccination, side effects, AstraZeneca, UK Pharmaceutical Regulatory Agency MHRA, European Pharmaceutical Regulatory Agency EMA, Bacillus Jung, Eunkyung Jung, blood clots, Pfizer blood clots